Journal Article
. 2006 Jul;24(19).
doi: 10.1200/JCO.2006.05.6564.

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer

Brian Z Ring 1 Robert S Seitz  Rod Beck  William J Shasteen  Shannon M Tarr  Maggie C U Cheang  Brian J Yoder  G Thomas Budd  Torsten O Nielsen  David G Hicks  Noel C Estopinal  Douglas T Ross  
Affiliations
  • PMID: 16809728
  •     55 citations

Abstract

Purpose: Patients with breast cancer experience progression and respond to treatment in diverse ways, but prognostic and predictive tools for the oncologist are limited. We have used gene expression data to guide the production of hundreds of novel antibody reagents to discover novel diagnostic tools for stratifying carcinoma patients.

Patients And Methods: One hundred forty novel and 23 commercial antisera, selected on their ability to differentially stain tumor samples, were used to stain paraffin blocks from a retrospective breast cancer cohort. Cox proportional hazards and regression tree analysis identified minimal panels of reagents able to predict risk of recurrence. We tested the prognostic association of these prospectively defined algorithms in two independent cohorts.

Results: In both validation cohorts, the Kaplan-Meier estimates of recurrence confirmed that both the Cox model using five reagents (p53, NDRG1, CEACAM5, SLC7A5, and HTF9C) and the regression tree model using six reagents (p53, PR, Ki67, NAT1, SLC7A5, and HTF9C) distinguished estrogen receptor (ER)-positive patients with poor outcomes. The Cox model was superior and distinguished patients with poor outcomes from patients with good or moderate outcomes with a hazard ratio of 2.21 (P = .0008) in validation cohort 1 and 1.88 (P = .004) in cohort 2. In multivariable analysis, the calculated risk of recurrence was independent of stage, grade, and lymph node status. A model proposed for ER-negative patients failed validation in the independent cohorts.

Conclusion: A panel of five antibodies can significantly improve on traditional prognosticators in predicting outcome for ER-positive breast cancer patients.

Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'.
Donal J Brennan, William M Gallagher.
Breast Cancer Res, 2008 Mar 12; 10(1). PMID: 18331621    Free PMC article.
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.
Douglas T Ross, Chung-Yeul Kim, +7 authors, Norman Wolmark.
Clin Cancer Res, 2008 Oct 18; 14(20). PMID: 18927301    Free PMC article.
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
Elton Rexhepaj, Donal J Brennan, +6 authors, William M Gallagher.
Breast Cancer Res, 2008 Oct 25; 10(5). PMID: 18947395    Free PMC article.
[Genome-wide expression profiling as a clinical tool: are we there yet?].
F C Geyer, T Decker, J S Reis-Filho.
Pathologe, 2009 Feb 17; 30(2). PMID: 19219435
Review.
A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients.
Brian D Piening, Pei Wang, Aravind Subramanian, Amanda G Paulovich.
Radiat Res, 2009 Mar 10; 171(2). PMID: 19267539    Free PMC article.
TLE3 as a candidate biomarker of response to taxane therapy.
Swati A Kulkarni, David G Hicks, +9 authors, Douglas T Ross.
Breast Cancer Res, 2009 Mar 25; 11(2). PMID: 19309506    Free PMC article.
Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer.
Attila Tordai, Cornelia Liedtke, Lajos Pusztai.
Clin Exp Metastasis, 2009 Apr 22; 26(7). PMID: 19381845
Review.
Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Jocelyne Jacquemier, Emmanuelle Charafe-Jauffret, +6 authors, Daniel Birnbaum.
Breast Cancer Res, 2009 May 02; 11(2). PMID: 19405945    Free PMC article.
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence.
David G Hicks, Bagi R Janarthanan, +13 authors, Douglas T Ross.
BMC Cancer, 2010 Mar 24; 10. PMID: 20307320    Free PMC article.
Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction.
M R Baneshi, P Warner, +3 authors, J M S Bartlett.
Br J Cancer, 2010 May 13; 102(10). PMID: 20461093    Free PMC article.
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.
John M S Bartlett, Jeremy Thomas, +12 authors, Udi Chetty.
Breast Cancer Res, 2010 Jul 10; 12(4). PMID: 20615243    Free PMC article.
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.
Donal J Brennan, Darran P O'Connor, +2 authors, William M Gallagher.
Nat Rev Cancer, 2010 Aug 20; 10(9). PMID: 20720569
Review.
Synthesis of a functional metal-chelating polymer and steps toward quantitative mass cytometry bioassays.
Daniel Majonis, Isaac Herrera, +5 authors, Mitchell A Winnik.
Anal Chem, 2010 Oct 14; 82(21). PMID: 20939532    Free PMC article.
Breast cancer in the personal genomics era.
Rachel E Ellsworth, David J Decewicz, Craig D Shriver, Darrell L Ellsworth.
Curr Genomics, 2010 Nov 03; 11(3). PMID: 21037853    Free PMC article.
Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.
E K A Millar, P H Graham, +10 authors, R L Sutherland.
Br J Cancer, 2011 Jun 30; 105(2). PMID: 21712826    Free PMC article.
Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.
Claudia Röwer, Björn Ziems, +6 authors, Michael O Glocker.
Int J Clin Exp Pathol, 2011 Jul 09; 4(5). PMID: 21738817    Free PMC article.
Predictive and prognostic molecular markers for cancer medicine.
Sunali Mehta, Andrew Shelling, +4 authors, Cristin Print.
Ther Adv Med Oncol, 2010 Mar 01; 2(2). PMID: 21789130    Free PMC article.
NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.
Lori M Millner, Mark A Doll, +2 authors, David W Hein.
Mol Carcinog, 2011 Aug 13; 51(8). PMID: 21837760    Free PMC article.
gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway.
Houria Boulaiz, Pablo J Alvarez, +8 authors, Antonia Aránega.
Int J Mol Sci, 2011 Dec 17; 12(11). PMID: 22174609    Free PMC article.
Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.
Csaba Juhász, Zeina Nahleh, +8 authors, Otto Muzik.
Nucl Med Biol, 2012 Mar 27; 39(7). PMID: 22444239    Free PMC article.
Can the centrosome be a marker for DNA ploidy in breast cancer?
Rita A Sakr, Jocelyne Fleury, +4 authors, Emile Darai.
J Cytol, 2012 Jul 13; 29(2). PMID: 22787290    Free PMC article.
A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.
Takayuki Kobayashi, Keiichi Iwaya, +4 authors, Osamu Matsubara.
BMC Clin Pathol, 2013 Feb 07; 13. PMID: 23384409    Free PMC article.
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
Patrick C O Leary, Sarah A Penny, +12 authors, William M Gallagher.
BMC Cancer, 2013 Apr 04; 13. PMID: 23547718    Free PMC article.
Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.
Michael J Gerdes, Christopher J Sevinsky, +28 authors, Fiona Ginty.
Proc Natl Acad Sci U S A, 2013 Jul 03; 110(29). PMID: 23818604    Free PMC article.
Highly Cited.
The functional and molecular entities underlying amino acid and peptide transport by the mammary gland under different physiological and pathological conditions.
D B Shennan, C A R Boyd.
J Mammary Gland Biol Neoplasia, 2013 Oct 26; 19(1). PMID: 24158403
Review.
Identification of gene expression signature in estrogen receptor positive breast carcinoma.
Arvind D Thakkar, Hemanth Raj, +5 authors, Muralidhara Padigaru.
Biomark Cancer, 2010 Jan 01; 2. PMID: 24179381    Free PMC article.
Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.
J Wason, A Marshall, +2 authors, N Stallard.
Br J Cancer, 2014 Mar 29; 110(8). PMID: 24667651    Free PMC article.
Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.
P Sinn, S Aulmann, +6 authors, A Schneeweiss.
Geburtshilfe Frauenheilkd, 2014 Apr 29; 73(9). PMID: 24771945    Free PMC article.
Predictive and prognostic value of the 21-gene recurrence score in hormone receptor-positive, node-positive breast cancer.
Adam M Brufsky.
Am J Clin Oncol, 2014 May 24; 37(4). PMID: 24853663    Free PMC article.
Systematic Review.
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.
J Stephen, G Murray, +13 authors, J M S Bartlett.
Br J Cancer, 2014 Oct 15; 111(12). PMID: 25314051    Free PMC article.
Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer.
Alexander Pearlman, Christopher Campbell, +8 authors, Harry Ostrer.
J Probab Stat, 2012 Jan 01; 2012(2012). PMID: 25419216    Free PMC article.
Emerging understanding of multiscale tumor heterogeneity.
Michael J Gerdes, Anup Sood, +3 authors, Fiona Ginty.
Front Oncol, 2015 Jan 08; 4. PMID: 25566504    Free PMC article.
Review.
Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.
Mona Zamanian-Azodi, Mostafa Rezaei-Tavirani, +2 authors, Sona Dalilan.
Gastroenterol Hepatol Bed Bench, 2015 Jan 15; 8(1). PMID: 25584171    Free PMC article.
Review.
FKBPL: a marker of good prognosis in breast cancer.
Laura Nelson, Hayley D McKeen, +27 authors, Tracy Robson.
Oncotarget, 2015 Apr 25; 6(14). PMID: 25906750    Free PMC article.
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.
Stephen G Dann, Michael Ryskin, +15 authors, Valeria R Fantin.
EMBO J, 2015 May 17; 34(13). PMID: 25979827    Free PMC article.
L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.
Qian Wang, Jeff Holst.
Am J Cancer Res, 2015 Jun 24; 5(4). PMID: 26101697    Free PMC article.
Highly Cited. Review.
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.
Claudia Cava, Gloria Bertoli, Isabella Castiglioni.
BMC Syst Biol, 2015 Sep 24; 9. PMID: 26391647    Free PMC article.
Review.
Using second harmonic generation to predict patient outcome in solid tumors.
K Burke, M Smid, +6 authors, E Brown.
BMC Cancer, 2015 Nov 26; 15. PMID: 26603532    Free PMC article.
High Expression of Three-Gene Signature Improves Prediction of Relapse-Free Survival in Estrogen Receptor-Positive and Node-Positive Breast Tumors.
Arvind Thakkar, Hemanth Raj, +3 authors, Muralidhara Padigaru.
Biomark Insights, 2015 Dec 10; 10. PMID: 26648682    Free PMC article.
Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients.
Xi Wang, Brian Z Ring, +5 authors, Shuyuan Yeh.
BMC Clin Pathol, 2015 Dec 15; 15. PMID: 26664297    Free PMC article.
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.
Xiaofeng Dai, Liangjian Xiang, Ting Li, Zhonghu Bai.
J Cancer, 2016 Jul 09; 7(10). PMID: 27390604    Free PMC article.
Highly Cited. Review.
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
Kun-Chun Chiang, Ta-Sen Yeh, +5 authors, Chun-Nan Yeh.
Sci Rep, 2016 Oct 27; 6. PMID: 27782193    Free PMC article.
Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation.
Tomohiro Enokida, Satoshi Fujii, +7 authors, Makoto Tahara.
Oncotarget, 2017 Oct 06; 8(37). PMID: 28977904    Free PMC article.
High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5α-androstane-3β,17β-Diol, or Dihydrotestosterone in Breast Cancer Cells.
Xiaoyan Zhang, Samantha M Carlisle, +4 authors, David W Hein.
J Pharmacol Exp Ther, 2018 Jan 18; 365(1). PMID: 29339455    Free PMC article.
Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.
Onur Esbah, Berna Oksuzoglu.
Indian J Med Res, 2018 Mar 08; 146(5). PMID: 29512598    Free PMC article.
Review.
Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
Yoon Jin Cha, Eun-Sol Kim, Ja Seung Koo.
Int J Mol Sci, 2018 Mar 23; 19(3). PMID: 29562706    Free PMC article.
Review.
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Azeez A Fatai, Junaid Gamieldien.
BMC Cancer, 2018 Apr 05; 18(1). PMID: 29614978    Free PMC article.
Informative three-dimensional survey of cell/tissue architectures in thick paraffin sections by simple low-vacuum scanning electron microscopy.
Akira Sawaguchi, Takeshi Kamimura, +4 authors, Yujiro Asada.
Sci Rep, 2018 May 12; 8(1). PMID: 29748574    Free PMC article.
NDRG1 regulates neutral lipid metabolism in breast cancer cells.
Christopher J Sevinsky, Faiza Khan, +3 authors, Douglas S Conklin.
Breast Cancer Res, 2018 Jun 15; 20(1). PMID: 29898756    Free PMC article.
Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
Rodney F Minchin, Neville J Butcher.
BMC Genomics, 2018 Jul 05; 19(1). PMID: 29969986    Free PMC article.
Cyclooxygenase-2 as a Biomarker with Diagnostic, Therapeutic, Prognostic, and Predictive Relevance in Small Animal Oncology.
Marta Szweda, Andrzej Rychlik, Izabella Babińska, Andrzej Pomianowski.
J Vet Res, 2020 Apr 08; 64(1). PMID: 32258812    Free PMC article.
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer.
Rokaya El Ansari, Lutfi Alfarsi, +4 authors, Andrew R Green.
Breast Cancer Res Treat, 2020 Mar 23; 181(1). PMID: 32200487    Free PMC article.
The Potential Use of Tumour-Based Prognostic and Predictive Tools in Older Women with Primary Breast Cancer: A Narrative Review.
Sophie Gordon-Craig, Ruth M Parks, Kwok-Leung Cheung.
Oncol Ther, 2020 Jul 24; 8(2). PMID: 32700048    Free PMC article.
Review.
LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target.
Khaldon Bodoor, Rowida Almomani, +2 authors, Walaa Samouri.
Asian Pac J Cancer Prev, 2020 May 28; 21(5). PMID: 32458655    Free PMC article.
Advanced Approaches to Breast Cancer Classification and Diagnosis.
M Zubair, S Wang, N Ali.
Front Pharmacol, 2021 Mar 16; 11. PMID: 33716731    Free PMC article.
Review.